1. Home
  2. NVAX vs RPD Comparison

NVAX vs RPD Comparison

Compare NVAX & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • RPD
  • Stock Information
  • Founded
  • NVAX 1987
  • RPD 2000
  • Country
  • NVAX United States
  • RPD United States
  • Employees
  • NVAX N/A
  • RPD N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • RPD Computer Software: Prepackaged Software
  • Sector
  • NVAX Health Care
  • RPD Technology
  • Exchange
  • NVAX Nasdaq
  • RPD Nasdaq
  • Market Cap
  • NVAX 1.3B
  • RPD 1.3B
  • IPO Year
  • NVAX 1995
  • RPD 2015
  • Fundamental
  • Price
  • NVAX $8.64
  • RPD $19.51
  • Analyst Decision
  • NVAX Buy
  • RPD Hold
  • Analyst Count
  • NVAX 7
  • RPD 19
  • Target Price
  • NVAX $14.29
  • RPD $27.00
  • AVG Volume (30 Days)
  • NVAX 6.9M
  • RPD 709.0K
  • Earning Date
  • NVAX 11-11-2025
  • RPD 11-05-2025
  • Dividend Yield
  • NVAX N/A
  • RPD N/A
  • EPS Growth
  • NVAX N/A
  • RPD N/A
  • EPS
  • NVAX 2.54
  • RPD 0.43
  • Revenue
  • NVAX $1,078,718,000.00
  • RPD $855,361,000.00
  • Revenue This Year
  • NVAX $61.69
  • RPD $2.75
  • Revenue Next Year
  • NVAX N/A
  • RPD $3.21
  • P/E Ratio
  • NVAX $3.18
  • RPD $45.07
  • Revenue Growth
  • NVAX 9.22
  • RPD 4.67
  • 52 Week Low
  • NVAX $5.01
  • RPD $17.83
  • 52 Week High
  • NVAX $15.22
  • RPD $44.48
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 60.46
  • RPD 42.41
  • Support Level
  • NVAX $7.83
  • RPD $19.36
  • Resistance Level
  • NVAX $8.31
  • RPD $21.26
  • Average True Range (ATR)
  • NVAX 0.37
  • RPD 0.62
  • MACD
  • NVAX 0.05
  • RPD -0.03
  • Stochastic Oscillator
  • NVAX 99.49
  • RPD 11.99

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About RPD Rapid7 Inc.

Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.

Share on Social Networks: